LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 15.58 | 27.76 | 560 | 685 | 0.8168 | 0.9144 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 15.58 | 27.76 | 1427 | 685 | 2.0815 | 1.3434 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 17.28 | 27.76 | 619 | 838 | 0.7380 | 0.8802 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 17.28 | 27.76 | 1064 | 838 | 1.2686 | 1.0992 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 17.28 | 27.76 | 1169 | 838 | 1.3938 | 1.1397 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 17.28 | 27.76 | 1509 | 838 | 1.7992 | 1.2537 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 18.98 | 27.76 | 789 | 941 | 0.8383 | 0.9318 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 18.98 | 27.76 | 1147 | 941 | 1.2187 | 1.0794 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 18.98 | 27.76 | 1467 | 941 | 1.5587 | 1.1825 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 18.98 | 27.76 | 1663 | 941 | 1.7670 | 1.2370 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 20.68 | 27.76 | 1109 | 1119 | 0.9911 | 0.9966 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 20.68 | 27.76 | 1253 | 1119 | 1.1197 | 1.0429 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 20.68 | 27.76 | 1703 | 1119 | 1.5219 | 1.1639 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 20.68 | 27.76 | 1837 | 1119 | 1.6416 | 1.1948 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 22.39 | 27.76 | 1265 | 1305 | 0.9688 | 0.9886 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 22.39 | 27.76 | 1354 | 1305 | 1.0370 | 1.0131 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 22.39 | 27.76 | 1899 | 1305 | 1.4544 | 1.1395 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 22.39 | 27.76 | 2002 | 1305 | 1.5333 | 1.1599 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 24.09 | 27.76 | 1381 | 1461 | 0.9448 | 0.9803 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 24.09 | 27.76 | 1456 | 1461 | 0.9961 | 0.9987 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 24.09 | 27.76 | 2020 | 1461 | 1.3820 | 1.1164 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 24.09 | 27.76 | 2108 | 1461 | 1.4422 | 1.1323 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 25.79 | 27.76 | 1499 | 1605 | 0.9339 | 0.9768 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 25.79 | 27.76 | 1560 | 1605 | 0.9719 | 0.9903 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 25.79 | 27.76 | 2235 | 1605 | 1.3924 | 1.1164 | MN20160318_Q01 | J07 |